Hyphens Pharma International (SGX:1J5) Other Net Income (Loss) : S$0.0 Mil (TTM As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Hyphens Pharma International Other Net Income (Loss)?

Hyphens Pharma International's Other Net Income (Loss) for the six months ended in Jun. 2023 was S$0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2023 was S$0.0 Mil.

Hyphens Pharma International's annual Other Net Income (Loss) declined from Dec. 2020 (S$0.0 Mil) to Dec. 2021 (S$0.0 Mil) but then stayed the same from Dec. 2021 (S$0.0 Mil) to Dec. 2022 (S$0.0 Mil).

Hyphens Pharma International Other Net Income (Loss) Historical Data

The historical data trend for Hyphens Pharma International's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyphens Pharma International Other Net Income (Loss) Chart

Hyphens Pharma International Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Net Income (Loss)

Get a 7-Day Free Trial

Hyphens Pharma International Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Other Net Income (Loss)	Get a 7-Day Free Trial										-	-	-	-	-

Hyphens Pharma International Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$0.0 Mil.

Hyphens Pharma International Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Hyphens Pharma International's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyphens Pharma International (SGX:1J5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyphens Pharma International Ltd (SGX:1J5) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Tai Seng Street, Level 4, Singapore, SGP, 534138

Website

https://www.hyphensgroup.com

Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.

Hyphens Pharma International (SGX:1J5) Headlines

No Headlines